Therapeutics for COVID-19 and post COVID-19 complications: An update
Open Access
- 1 January 2022
- journal article
- review article
- Published by Elsevier BV in Current Research in Pharmacology and Drug Discovery
- Vol. 3, 100086
- https://doi.org/10.1016/j.crphar.2022.100086
Abstract
No abstract availableKeywords
This publication has 114 references indexed in Scilit:
- Red and orange flags for secondary headaches in clinical practiceNeurology, 2019
- Diagnostic performance of ATA, BTA and TIRADS sonographic patterns in the prediction of malignancy in histologically proven thyroid nodulesSingapore Medical Journal, 2018
- Type 1 diabetesThe Lancet, 2018
- Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and MyocarditisJournal of the American College of Cardiology, 2015
- Actinomycosis: etiology, clinical features, diagnosis, treatment, and managementInfection and Drug Resistance, 2014
- Faecalibacterium prausnitzii and human intestinal healthCurrent Opinion in Microbiology, 2013
- The Role of Nuclear Factor κB in the Interferon ResponseJournal of Interferon & Cytokine Research, 2011
- Propranolol Decreases Tachycardia and Improves Symptoms in the Postural Tachycardia SyndromeJournal of the American College of Cardiology, 2009
- Characterization of the genusPseudozymaby the formation of glycolipid biosurfactants, mannosylerythritol lipidsFEMS Yeast Research, 2007
- Inhaled nitric oxide applications in paediatric practice2002